Abstract
Launching new drugs is getting more and more difficult for healthcare companies that need to manage a more complex customer environment and address the challenge of market access. This paper studies the reasons behind the market access question taking the perspective of the industry and its customers. Implications on organisation in terms of competencies but also culture and leadership requirements are discussed.
Get full access to this article
View all access options for this article.